NPL2009
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NPL2009, covering 2012-04-27 to 2012-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome [Phase 1, Phase 2]